Indivior PLC Profile Avatar - Palmy Investing

Indivior PLC

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treatin…

Drug Manufacturers - Specialty & Generic
US, North Chesterfield [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Indivior PLC mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of INDV.L's Analysis
CIK: - CUSIP: G4766E108 ISIN: GB00BN4HT335 LEI: - UEI: -
Secondary Listings